Immunotherapy Clinical Trial Aims To Combat Brain Cancer – New Jersey Hills
New Jersey Hills |
Immunotherapy Clinical Trial Aims To Combat Brain Cancer
New Jersey Hills “The Phase 1 results of this promising immunotherapy reported a 40% probability of survival at two years for patients with recurrent glioblastoma,” Dr. Moshel continues. “It's been very hard to get these kinds of results with such an aggressive and … |
